Today: 24 March 2026
Subscribe
Browse Category

Stock Market 12 January 2026

Vistra stock jumps as VST taps debt markets; analysts recalibrate after Meta nuclear pact

Vistra stock jumps as VST taps debt markets; analysts recalibrate after Meta nuclear pact

Vistra shares rose about 5% Monday after announcing a private offering of senior secured notes maturing in 2031 and 2036. Proceeds will fund the Cogentrix acquisition and repay debt. The company recently signed 20-year nuclear power agreements with Meta for over 2,600 megawatts. Traders are watching note pricing ahead of Vistra’s Feb. 26 earnings report.
12 January 2026
··
Tesla stock rises in regular session as CPI looms and robotaxi deadlines return to focus

Tesla stock rises in regular session as CPI looms and robotaxi deadlines return to focus

Tesla shares rose 0.7% to $448.09 Monday as investors awaited Tuesday’s U.S. inflation report and the company’s Jan. 28 earnings release. Roughly 23.7 million shares traded by late morning. Tesla reported over 434,000 vehicles produced and 418,000 delivered in Q4. Wall Street remains focused on Fed rate moves and Tesla’s progress on autonomy targets.
12 January 2026
····
Revolution Medicines stock slips as Truist sticks to $99 target with Merck buyout talk in focus

Revolution Medicines stock slips as Truist sticks to $99 target with Merck buyout talk in focus

Revolution Medicines shares fell 1.8% to $116.51 in early Monday trading, retreating from last week’s highs after reports of ongoing Merck acquisition talks valuing the company at up to $32 billion. Truist maintained its Buy rating but kept its price target at $99, below the current price. Investors await the company’s presentation at the J.P. Morgan Healthcare Conference later Monday.
12 January 2026
··
Applied Digital (APLD) stock is up again — what’s driving the move after hyperscaler leases

Applied Digital (APLD) stock is up again — what’s driving the move after hyperscaler leases

Applied Digital shares rose about 2.5% to $38.61 in late-morning New York trading Monday, extending last week’s post-earnings rally. Investors are focused on leasing progress and funding for the company’s North Dakota AI data centers. The company recently reported $126.6 million in quarterly revenue, beating estimates, but posted a net loss of $31.2 million. Traders await new contract updates and Tuesday’s U.S. CPI report.
12 January 2026
··
Alphabet hits $4 trillion mark as Google’s AI reboot wins back Wall Street

Alphabet hits $4 trillion mark as Google’s AI reboot wins back Wall Street

Alphabet’s market value reached $4 trillion Monday, surpassing Apple and joining only three other companies at that level. Shares dipped 0.2% to $327.93 late morning after a 65% jump in 2025. Google Cloud revenue surged 34% in Q3, and Alphabet began leasing its in-house AI chips, with Meta reportedly in talks for a multi-billion dollar deal.
12 January 2026
···
AMD stock jumps as Bernstein stays cautious on chipmaker and Wall Street frets Fed fight

AMD stock jumps as Bernstein stays cautious on chipmaker and Wall Street frets Fed fight

AMD shares rose 2.6% to $208.44 by 10:31 a.m. EST Monday, outperforming a slightly lower Nasdaq 100. Analyst Stacy Rasgon kept AMD at “market perform,” citing Nvidia’s growing lead in AI chips. Nvidia was flat, Broadcom gained 1.9%, and Intel fell 1.1%. AMD reports quarterly results Feb. 3.
12 January 2026
········
Plug Power stock rises as UBS conference nears and Jan. 29 vote raises reverse-split stakes

Plug Power stock rises as UBS conference nears and Jan. 29 vote raises reverse-split stakes

Plug Power shares rose 4.1% to $2.28 Monday as investors focused on a Jan. 29 vote to double authorized shares to 3 billion. The company warned it will pursue a reverse stock split if the proposal fails. Last week, Plug amended a Walmart deal, removing the risk of diluting 42.2 million shares. Executives are scheduled to present at the UBS energy conference later today.
12 January 2026
··
Alphabet stock’s $4 trillion flashpoint: Google’s AI refocus puts it back in the lead

Alphabet stock’s $4 trillion flashpoint: Google’s AI refocus puts it back in the lead

Alphabet briefly topped a $4 trillion valuation Monday after unveiling a new AI strategy, before shares slipped 0.3% to $327.47 by late morning. Investors are watching Google Cloud’s expansion, early reviews of the Gemini 3 model, and efforts to rent out proprietary “Ironwood” AI chips. Reuters reported Meta may buy Alphabet’s chips for its data centers starting in 2027.
12 January 2026
···
Nvidia stock wobbles after $1B Eli Lilly AI lab plan as CPI and TSMC loom

Nvidia stock wobbles after $1B Eli Lilly AI lab plan as CPI and TSMC loom

Nvidia and Eli Lilly will invest $1 billion over five years in a joint research lab in the San Francisco Bay Area, aiming to use Nvidia’s new AI chips to accelerate drug discovery. Nvidia shares slipped 0.2% to $184.42 by 10:30 a.m. ET. Thermo Fisher Scientific will also collaborate with Nvidia on lab automation. The new site is expected to open by the end of March.
12 January 2026
····
Applied Materials stock rises on Susquehanna upgrade as chip gear spending call widens

Applied Materials stock rises on Susquehanna upgrade as chip gear spending call widens

Applied Materials rose 1.7% to $306.35 in early New York trading after Susquehanna upgraded the stock to Positive and raised its price target to $400. The move followed analyst Mehdi Hosseini’s report citing stronger wafer fab equipment demand and higher semiconductor capital spending. The S&P 500 and Nasdaq-100 slipped, while other chip equipment stocks saw modest gains.
12 January 2026
····
Eli Lilly stock edges up as $1 billion Nvidia AI lab plan hits JPM spotlight

Eli Lilly stock edges up as $1 billion Nvidia AI lab plan hits JPM spotlight

Eli Lilly shares rose about 0.7% Monday after announcing a $1 billion, five-year AI drug discovery lab partnership with Nvidia. The Bay Area facility, using Nvidia’s Vera Rubin chips, will open in March with teams from both firms. Investors are watching for updates from CEO David Ricks at the J.P. Morgan Healthcare Conference on Tuesday and Lilly’s earnings call on Feb. 4.
12 January 2026
······
Jaguar Health stock swings as Future Pak licensing deal dangles $38 million — here’s what traders see

Jaguar Health stock swings as Future Pak licensing deal dangles $38 million — here’s what traders see

Jaguar Health shares fell about 9% Monday after announcing a U.S. licensing deal with Future Pak for exclusive rights to Mytesi and Canalevia-CA1, potentially worth up to $38 million. The stock traded between $0.94 and $1.45 on heavy volume. Jaguar will receive $18 million upfront and may get up to $20 million more in milestone payments, while shifting its U.S. commercial focus to Future Pak.
12 January 2026
·
Moderna stock slides as $1.9 billion sales view fails to calm investors (MRNA)

Moderna stock slides as $1.9 billion sales view fails to calm investors (MRNA)

Moderna shares fell 4% to $32.92 Monday after the company raised its 2025 revenue forecast to $1.9 billion and projected operating expenses of up to $5.2 billion. CFO Jamey Mock said U.S. retail vaccination rates dropped 26% in 2025. The company expects about $8.1 billion in year-end cash, including $600 million from a new loan. Investors remain cautious as pandemic demand fades and late-stage vaccine trial results approach.
12 January 2026
···
Silver price stock SLV jumps nearly 7% as Fed probe headlines push silver to fresh records

Silver price stock SLV jumps nearly 7% as Fed probe headlines push silver to fresh records

Spot silver jumped above $85 an ounce Monday, triggering a 6.9% surge in iShares Silver Trust (SLV) to $77.40 on heavy volume. The rally followed news of grand jury subpoenas for Fed Chair Jerome Powell, raising concerns about central bank independence and weakening the dollar. Traders are watching for Tuesday’s U.S. CPI data and the Fed’s late-January meeting.
12 January 2026
·····
1 … 536 537 538 539 540 … 1,361

Stock Market Today

  • Brazil's Strong Coffee Crop Outlook Pressures Coffee Prices Lower
    March 24, 2026, 4:58 AM EDT. Coffee prices dropped Monday as favorable conditions in Brazil suggest a strong 2026/27 crop, dampening market concerns. May arabica and robusta futures fell by 0.89% and 0.74%, respectively. Beneficial soil moisture and expected rains support crop development in key growing areas like Minas Gerais. StoneX boosted Brazil's 2026/27 coffee production forecast to a record 75.3 million bags, increasing supply expectations. Meanwhile, robusta inventories hit a two-month low, yet arabica stocks rose to a 5.75-month peak. Global dynamics add complexity: the Strait of Hormuz closure earlier tightened supplies and boosted costs, while Vietnam's coffee exports increased 14% year-on-year, pressuring robusta prices. Recent declines in Brazil's February coffee exports further contribute to market uncertainty.
Go toTop